Comorbid Alcohol and Substance Abuse Dependence in Depression: Impact on the Outcome of Antidepressant Treatment

Psychiatric Clinics of North America

Volumn 30, Issue 1, 2007, Pages 69-76

  Ostacher, Michael J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; MIRTAZAPINE; NEFAZODONE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ALCOHOLISM; DEPRESSION; HUMAN; MAJOR DEPRESSION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SUBSTANCE ABUSE;

ALCOHOLISM; ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; HUMANS; PREVALENCE; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 33847742557     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2006.12.009     Document Type: Review

References (23)

1. Grant B.F., Stinson F.S., Dawson D.A., et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Arch Gen Psychiatry 61 (2004) 807-816
2. Kessler R.C., Berglund P., Demler O., et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 (2003) 3095-3105
3. Kessler R.C., and Walters E.E. The National Comorbidity Survey. In: Tsaung M.T., and Tohen M. (Eds). Textbook in psychiatric epidemiology. 2nd edition (2002), John Wiley & Sons Inc, New York 343-362
4. Sanderson K., and Andrews G. Prevalence and severity of mental health disability and relationship to diagnosis. Psychiatr Serv 53 (2002) 80-86
5. Nurnberger Jr. J.I., Foroud T., Flury L., et al. Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. Am J Psychiatry 158 (2001) 718-724
6. Wang J.C., Hinrichs A.L., Stock H., et al. Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum Mol Genet 13 (2004) 1903-1911
7. Davis L.L., Rush J.A., Wisniewski S.R., et al. Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort. Compr Psychiatry 46 (2005) 81-89
8. Nunes E.V., Liu X., Samet S., et al. Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up. J Clin Psychiatry 67 (2006) 1561-1567
9. Hasin D.S., and Grant B.F. Major depression in 6,050 former drinkers. Arch Gen Psychiatry 59 (2002) 794-800
10. Hasin D., Liu X., Nunes E., et al. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry 59 (2002) 375-380
11. Regier D.A., Farmer M.E., Rae D.S., et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264 (1990) 2511-2518
12. Schuckit M.A., Tipp J.E., Bergman M., et al. Comparison of induced and independent major depressive disorder in 2,945 alcoholics. Am J Psychiatry 154 (1997) 948-957
13. Conway K.P., Compton W., Stinson F.S., and Grant B.F. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67 2 (Feb 2006) 247-257
14. Greenfield S., Weiss R., Nuenz L., et al. The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry 55 (1998) 269-265
15. Sher L., Oquendo M.A., Galfalvy H.C., et al. The relationship of aggression to suicidal behavior in depressed patients with a history of alcoholism. Addict Behav 30 (2005) 1144-1153
16. Gilmer W.S., Trivedi M.H., Rush A.J., et al. Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatr Scand 112 (2005) 425-433
17. Nunes E.V., and Levin F.R. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA 291 (2004) 1887-1896
18. Kranzler H.R. Evidence-based treatments for alcohol dependence: new results and new questions. JAMA 295 (2006) 2075-2076
19. Watkins K.E., Paddock S.M., Zhang L., et al. Improving care for depression in patients with comorbid substance misuse. Am J Psychiatry 163 (2006) 125-132
20. Cornelius J.R., Salloum I.M., Haskett R.F., et al. Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study. Addict Behav 25 (2000) 307-310
21. Mason B.J., Kocsis J.H., Ritvo E.C., et al. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on presence or absence of major depression. JAMA 275 (1996) 761-767
22. McGrath P.J., Nunes E.V., Stewart J.W., et al. Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial. Arch Gen Psychiatry 53 (1996) 232-240
23. Nunes E.V., Quitkin F.M., Donovan S.J., et al. Imipramine treatment of opiate-dependent patients with depressive disorders: a placebo-controlled trial. Arch Gen Psychiatry 55 (1998) 153-160